Search Results - "Lopez‐Quesada, Eva"

Mid‐trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre‐eclampsia: Post‐hoc analysis of StopPRE trial by Bonacina, Erika, Garcia‐Manau, Pablo, López, Monica, Caamiña, Sara, Vives, Àngels, Lopez‐Quesada, Eva, Ricart, Marta, Maroto, Anna, Mingo, Laura, Pintado, Elena, Castillo‐Ribelles, Laura, Martín, Lourdes, Rodriguez‐Zurita, Alicia, Garcia, Esperanza, Pallarols, Mar, Vidal‐Sagnier, Laia, Teixidor, Mireia, Orizales‐Lago, Carmen, Pérez‐Gomez, Adela, Ocaña, Vanesa, Puerto, Linda, Millán, Pilar, Alsius, Mercè, Diaz, Sonia, Maiz, Nerea, Carreras, Elena, Suy, Anna, Mendoza, Manel

“…Objective To assess whether aspirin treatment can be discontinued in pregnancies with normal uterine artery pulsatility index (≤90th percentile) at 24–28…”
Get full text

Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor by Garcia‐Manau, Pablo, Bonacina, Erika, Serrano, Berta, Caamiña, Sara, Ricart, Marta, Lopez‐Quesada, Eva, Vives, Àngels, Lopez, Monica, Pintado, Elena, Maroto, Anna, Catalan, Sara, Dalmau, Marta, Del Barco, Ester, Hernandez, Alina, Miserachs, Marta, San Jose, Marta, Armengol‐Alsina, Mireia, Carreras, Elena, Mendoza, Manel

“…Introduction Pre‐eclampsia affects 2%–8% of pregnancies and is one of the leading causes of maternal and perinatal morbidity and mortality. First‐trimester…”
Get full text

Implementation of routine first‐trimester combined screening for preeclampsia based on the Gaussian algorithm: A clinical effectiveness study by Mendoza, Manel, Bonacina, Erika, Serrano, Berta, Ricart, Marta, Martin, Lourdes, Lopez‐Quesada, Eva, Vives, Angels, Maroto, Anna, Garcia‐Manau, Pablo, De Antonio, Clementina, Tusquets, Cristina, Moreano, Gabriela, Armengol‐Alsina, Mireia, Carreras, Elena

“…Objective To evaluate the clinical effectiveness of the routine first‐trimester screening for preeclampsia (PE) after being implemented in six Catalan…”
Get full text

Impact of thyroid universal screening on pregnancy outcomes in real‐world clinical practice by Orois, Aida, López‐Quesada, Eva, Jalencas, Gloria, Barahona, María‐José, Perea, Verónica

Get full text

Placental growth factor at 24–28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial by Ricart, Marta, Bonacina, Erika, Garcia‐Manau, Pablo, López, Monica, Caamiña, Sara, Vives, Àngels, Lopez‐Quesada, Eva, Maroto, Anna, Mingo, Laura, Pintado, Elena, Ferrer‐Costa, Roser, Martín, Lourdes, Rodriguez‐Zurita, Alicia, Garcia, Esperanza, Pallarols, Mar, Pratcorona, Laia, Teixidor, Mireia, Orizales‐Lago, Carmen, Ocaña, Vanesa, Barco, Esther, Carreras, Elena, Suy, Anna, Mendoza, Manel

“…Introduction This study aims to evaluate the safety of discontinuing aspirin treatment at 24–28 weeks in women at high risk after first‐trimester combined…”
Get full text

Shared risk factors for COVID‐19 and preeclampsia in the first trimester: An observational study by Serrano, Berta, Mendoza, Manel, Garcia‐Aguilar, Paula, Bonacina, Erika, Garcia‐Ruiz, Itziar, Garcia‐Manau, Pablo, Gil, Judit, Armengol‐Alsina, Mireia, Fernandez‐Hidalgo, Nuria, Sulleiro, Elena, Lopez‐Martinez, Rosa Maria, Ricart, Marta, Martin, Lourdes, Lopez‐Quesada, Eva, Vives, Angels, Maroto, Anna, Maiz, Nerea, Suy, Anna, Carreras, Elena

“…Introduction The association between preeclampsia and coronavirus disease 2019 (COVID‐19) is under study. Previous publications have hypothesized the existence…”
Get full text

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial by Garcia-Manau, Pablo, Mendoza, Manel, Bonacina, Erika, Martin-Alonso, Raquel, Martin, Lourdes, Palacios, Ana, Sanchez, Maria Luisa, Lesmes, Cristina, Hurtado, Ivan, Perez, Esther, Tubau, Albert, Ibañez, Patricia, Alcoz, Marina, Valiño, Nuria, Moreno, Elena, Borrero, Carlota, Garcia, Esperanza, Lopez-Quesada, Eva, Diaz, Sonia, Broullon, Jose Roman, Teixidor, Mireia, Chulilla, Carolina, Gil, Maria M, Lopez, Monica, Candela-Hidalgo, Amparo, Salinas-Amoros, Andrea, Moreno, Anna, Morra, Francesca, Vaquerizo, Oscar, Soriano, Beatriz, Fabre, Marta, Gomez-Valencia, Elena, Cuiña, Ana, Alayon, Nicolas, Sainz, Jose Antonio, Vives, Angels, Esteve, Esther, Ocaña, Vanesa, López, Miguel Ángel, Maroto, Anna, Carreras, Elena

“…Background: Fetal smallness affects 10% of pregnancies. Small fetuses are at a higher risk of adverse outcomes. Their management using estimated fetal weight…”
Get full text

Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia by López-Quesada, Eva, Vilaseca, M.Antonia, Lailla, Jose M.

“…Objectives: (a) To establish the reference values for plasma total homocysteine in our pregnant population. (b) To determine the possible association between…”
Get full text

Next-Generation Sequencing Gene Panels and "Solo" Clinical Exome Sequencing Applied in Structurally Abnormal Fetuses by Pauta, Montse, Campos, Berta, Segura-Puimedon, Maria, Arca, Gemma, Nadal, Alfons, Tubau, Albert, Perez, Silvia Pina, Marimon, Edda, Martín, Lourdes, López-Quesada, Eva, Sabrià, Joan, Muñoz, Begoña, Garcia, Esperanza, Paz Y Miño, Fernanda, Borobio, Virginia, Gomez, Olga, Eixarch, Elisenda, Lopez, Monica, Comas Rovira, Montserrat, Borrell, Antoni

“…The aim of the study was to assess the diagnostic yield of 2 different next-generation sequencing (NGS) approaches: gene panel and "solo" clinical exome…”
Get more information

Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial by Mendoza, Manel, Bonacina, Erika, Garcia-Manau, Pablo, López, Monica, Caamiña, Sara, Vives, Àngels, Lopez-Quesada, Eva, Ricart, Marta, Maroto, Anna, de Mingo, Laura, Pintado, Elena, Ferrer-Costa, Roser, Martin, Lourdes, Rodríguez-Zurita, Alicia, Garcia, Esperanza, Pallarols, Mar, Vidal-Sagnier, Laia, Teixidor, Mireia, Orizales-Lago, Carmen, Pérez-Gomez, Adela, Ocaña, Vanesa, Puerto, Linda, Millán, Pilar, Alsius, Mercè, Diaz, Sonia, Maiz, Nerea, Carreras, Elena, Suy, Anna

“…Aspirin reduces the incidence of preterm preeclampsia by 62% in pregnant individuals at high risk of preeclampsia. However, aspirin might be associated with an…”
Get full text

Placental growth factor at 24–28weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial by Ricart, Marta, Bonacina, Erika, Pablo Garcia‐Manau, López, Monica, Caamiña, Sara, Vives, Àngels, Eva Lopez‐Quesada, Maroto, Anna, de Mingo, Laura, Pintado, Elena, Roser Ferrer‐Costa, Martín, Lourdes, Alicia Rodriguez‐Zurita, Garcia, Esperanza, Mar Pallarols, Pratcorona, Laia, Teixidor, Mireia, Carmen Orizales‐Lago, Ocaña, Vanesa, Esther del Barco, Carreras, Elena, Suy, Anna, Mendoza, Manel

“…IntroductionThis study aims to evaluate the safety of discontinuing aspirin treatment at 24–28 weeks in women at high risk after first‐trimester combined…”
Get full text

Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial by Mendoza, Manel, Bonacina, Erika, Garcia-Manau, Pablo, López, Monica, Caamiña, Sara, Vives, Àngels, Lopez-Quesada, Eva, Ricart, Marta, Maroto, Anna, de Mingo, Laura, Pintado, Elena, Ferrer-Costa, Roser, Martin, Lourdes, Rodríguez-Zurita, Alicia, Garcia, Esperanza, Pallarols, Mar, Vidal-Sagnier, Laia, Teixidor, Mireia, Orizales-Lago, Carmen, Pérez-Gomez, Adela, Ocaña, Vanesa, Puerto, Linda, Millán, Pilar, Alsius, Mercè, Diaz, Sonia, Maiz, Nerea, Carreras, Elena, Suy, Anna

“…Preeclampsia affects up to 4% of pregnancies and is marked by the development of hypertension and proteinuria after 20 weeks of gestation. Complications…”
Get full text

Are plasma total homocysteine and other amino acids associated with glucose intolerance in uncomplicated pregnancies and preeclampsia? by López-Quesada, Eva, Antònia Vilaseca, M., Gómez, Elena, Lailla, Josep M.

“…Objective: To evaluate the possible association between plasma total homocysteine or other amino acid concentrations and gestational diabetes or glucose…”
Get full text

Perinatal outcome prediction by maternal homocysteine and uterine artery Doppler velocimetry by López-Quesada, Eva, Vilaseca, M.Antonia, Vela, Antonio, Lailla, Josep M.

“…Objectives: (a) To evaluate the predictive value of uterine Doppler velocimetry for pregnancy complications, (b) to study the relationship between abnormal…”
Get full text

Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies by Also-Rallo, Eva, Lopez-Quesada, Eva, Urreizti, Roser, Vilaseca, M. Antònia, Lailla, Josep M., Balcells, Susana, Grinberg, Daniel

“…To evaluate the possible relationship between preeclampsia and polymorphisms in the main genes involved in folate-homocysteine metabolism. Case-control study:…”
Get full text

Homocysteine and other plasma amino acids in preeclampsia and in pregnancies without complications by López-Quesada, Eva, Vilaseca, Maria-Antònia, Artuch, Rafael, Gómez, Elena, Lailla, Josep M

“…To evaluate a) the plasma amino acid changes observed in pregnant women ( n = 124) and b) the homocysteine and other amino acid changes in preeclampsic…”
Get full text

Hyperhomocysteinemia during pregnancy as a risk factor of preeclampsia by López-Quesada, Eva, Also-Rayo, Eva, Vilaseca, M Antonia

“…A revision about the role of hyperhomocysteinemia in the development of preeclampsia is presented, which summarises our experience in different biochemical and…”
Get more information